{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:49:27Z","timestamp":1790776167681,"version":"4.1.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,3,24]],"date-time":"2005-03-24T00:00:00Z","timestamp":1111622400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00262-004-0657-y","type":"journal-article","created":{"date-parts":[[2005,3,23]],"date-time":"2005-03-23T13:12:11Z","timestamp":1111583531000},"page":"953-970","source":"Crossref","is-referenced-by-count":32,"title":["Serum-free generation and quantification of functionally active Leukemia-derived DC is possible from malignant blasts in acute myeloid leukemia and myelodysplastic syndromes"],"prefix":"10.1007","volume":"54","author":[{"given":"S.","family":"Kufner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Pelka","family":"Fleischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Kroell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zitzelsberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. de","family":"Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Treder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. M.","family":"Schmetzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,3,24]]},"reference":[{"issue":"14","key":"657_CR1","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJM200010053431407","volume":"343","author":"UH Andrian von","year":"2000","unstructured":"von Andrian UH, Mackay CR (2000) T-cell function and migration. Two sides of the same coin. N Engl J Med 343(14):1020\u20131034","journal-title":"N Engl J Med"},{"issue":"3","key":"657_CR2","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/sj.leu.2402810","volume":"17","author":"FR Appelbaum","year":"2003","unstructured":"Appelbaum FR (2003) New targets for therapy in acute myeloid leukemia. Leukemia 17(3):492\u2013495","journal-title":"Leukemia"},{"issue":"11","key":"657_CR3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00063-002-1210-4","volume":"97","author":"C Aul","year":"2002","unstructured":"Aul C, Giagounidis A, Germing U, Ganser A (2002) Myelodysplastic syndromes. Diagnosis and therapeutic strategies. Med Klin 97(11):666\u2013676","journal-title":"Med Klin"},{"issue":"12","key":"657_CR4","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0145-2126(01)00084-4","volume":"25","author":"L Balaian","year":"2001","unstructured":"Balaian L, Ball ED (2001) Direct effect of bispecific anti-CD33\u00d7anti-CD64 antibody on proliferation and signaling in myeloid cells. Leuk Res 25(12):1115\u20131125","journal-title":"Leuk Res"},{"issue":"4","key":"657_CR5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1365-2141.1976.tb03563.x","volume":"33","author":"JM Bennett","year":"1976","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al (1976) Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 33(4):451\u2013458","journal-title":"Br J Haematol"},{"issue":"2","key":"657_CR6","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","volume":"51","author":"JM Bennett","year":"1982","unstructured":"Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al (1982) Proposals for the classification of the myelodysplastic syndromes. Br J Haematol 51(2):189\u2013199","journal-title":"Br J Haematol"},{"issue":"5","key":"657_CR7","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.4049\/jimmunol.166.5.3174","volume":"166","author":"BR Blazar","year":"2001","unstructured":"Blazar BR, Kwon BS, Panoskaltsis-Mortari A, Kwak KB, Peschon JJ, Taylor PA (2001) Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus-leukemia, and graft rejection in allogeneic bone marrow transplant recipients. J Immunol 166(5):3174\u20133183","journal-title":"J Immunol"},{"key":"657_CR8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1473-0502(02)00041-1","volume":"27","author":"P Brossart","year":"2002","unstructured":"Brossart P (2002) Dendritic cells in vaccination therapies of malignant diseases. Transfus Apher Sci 27:183\u2013186","journal-title":"Transfus Apher Sci"},{"issue":"11","key":"657_CR9","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1182\/blood.V92.11.4238","volume":"92","author":"P Brossart","year":"1998","unstructured":"Brossart P, Grunebach F, Stuhler G, Reichardt VL, Mohle R, Kanz L et al (1998) Generation of functional human dendritic cells from adherent peripheral blood monocytes by CD40 ligation in the absence of granulocyte-macrophage colony-stimulating factor. Blood 92(11):4238\u20134247","journal-title":"Blood"},{"issue":"6","key":"657_CR10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1089\/152581600750062372","volume":"9","author":"O Bruserud","year":"2000","unstructured":"Bruserud O, Gjertsen BT, von Volkman HL (2000) In vitro culture of human acute myelogenous leukemia (AML) cells in serum-free media: studies of native AML blasts and AML cell lines. J Hematother Stem Cell Res 9(6):923\u2013932","journal-title":"J Hematother Stem Cell Res"},{"issue":"24","key":"657_CR11","doi-asserted-by":"crossref","first-page":"4496","DOI":"10.1200\/JCO.2003.02.133","volume":"21","author":"T Buechner","year":"2003","unstructured":"Buechner T, Hiddemann W, Berdel WE, Wormann B, Schoch C, Fonatsch C et al (2003) 6-Thioguanine, cytarabine, and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced monthly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative Group. J Clin Oncol 21(24):4496\u20134504","journal-title":"J Clin Oncol"},{"issue":"11","key":"657_CR12","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1080\/1042819021000033015","volume":"43","author":"D Bunjes","year":"2002","unstructured":"Bunjes D (2002) 188Re-labeled anti-CD66 monoclonal antibody in stem cell transplantation for patients with high-risk acute myeloid leukemia. Leukemia Lymphoma 43(11):2125\u20132131","journal-title":"Leukemia Lymphoma"},{"key":"657_CR13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0022-1759(00)00228-3","volume":"243","author":"D Campana","year":"2000","unstructured":"Campana D, Behm FG (2000) Immunophenotyping of leukemia. J Immunol Methods 243:59\u201375","journal-title":"J Immunol Methods"},{"key":"657_CR14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood.V90.4.1458","volume":"4","author":"C Caux","year":"1997","unstructured":"Caux C, Massacrier C, Vanbervliet B, Dubois B, Durand I, Cella M et al (1997) CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to granulocyte-macrophage colony-stimulating factor plus tumor necrosis factor \u00e1: II functional analysis. Blood 4:1458\u20131470","journal-title":"Blood"},{"key":"657_CR15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0952-7915(97)80153-7","volume":"9","author":"M Cella","year":"1997","unstructured":"Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9:10\u201316","journal-title":"Curr Opin Immunol"},{"issue":"8","key":"657_CR16","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1002\/(SICI)1521-4141(199908)29:08<2567::AID-IMMU2567>3.0.CO;2-S","volume":"29","author":"A Charbonnier","year":"1999","unstructured":"Charbonnier A, Gaugler B, Sainty D, Lafage-Pochitaloff M, Olive D (1999) Human acute myeloblastic leukemia cells differentiate in vitro into mature dendritic cells and induce the differentiation of cytotoxic T cells against autologous leukemias. Eur J Immunol 29(8):2567\u20132578","journal-title":"Eur J Immunol"},{"issue":"3","key":"657_CR17","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1182\/blood.V93.3.780","volume":"93","author":"A Choudhury","year":"1999","unstructured":"Choudhury A, Liang JC, Thomas EK, Flores-Romo L, Xie QS, Agusala K et al (1999) Dendritic cells derived in vitro from acute myelogenous leukemia cells stimulate autologous, antileukemic T-cell responses. Blood 93(3):780\u2013786","journal-title":"Blood"},{"key":"657_CR18","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1615\/CritRevImmunol.v21.i1-3.100","volume":"21","author":"DF Claxton","year":"2001","unstructured":"Claxton DF, McMannis J, Champlin R, Choudhury A (2001) Therapeutic potential of leukemia-derived dendritic cells: preclinical and clinical progress. Crit Rev Immunol 21:147\u2013155","journal-title":"Crit Rev Immunol"},{"issue":"5","key":"657_CR19","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00002371-200209000-00007","volume":"25","author":"IJ Vries De","year":"2002","unstructured":"De Vries IJ, Eggert AA, Scharenborg NM, Vissers JL, Lesterhuis WJ, Boerman OC, Punt CJ, Adema GJ, Figdor CG (2002) Phenotypical and functional characterization of clinical grade dendritic cells. J Immunother 25(5):429\u2013438","journal-title":"J Immunother"},{"issue":"5594","key":"657_CR20","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.1076514","volume":"298","author":"ME Dudley","year":"2002","unstructured":"Dudley ME, Wunderlich JR, Robbins PF, Yang JC, Hwu P, Schwartzentruber DJ, Topalian SL, Sherry R, Restifo NP, Hubicki AM, Robinson MR, Raffeld M, Duray P, Seipp CA, Rogers-Freezer L, Morton KE, Mavroukakis SA, White DE, Rosenberg SA (2002) Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594):850\u2013854","journal-title":"Science"},{"issue":"12","key":"657_CR21","first-page":"1104","volume":"83","author":"MT Elghetany","year":"1998","unstructured":"Elghetany MT (1998) Surface marker abnormalities in myelodysplastic syndromes. Haematologica 83(12):1104\u20131115","journal-title":"Haematologica"},{"issue":"2","key":"657_CR22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ijc.11053","volume":"105","author":"U Erben","year":"2003","unstructured":"Erben U, Thiel E, Bittroff-Leben A, Schoch C, Fichtner I, Durkop H, Notter M (2003) CS-1, a novel c-kithi+ acute myeloid leukemia cell line with dendritic cell differentiation capacity and absent immunogenicity. Int J Cancer 105(2):232\u2013240","journal-title":"Int J Cancer"},{"key":"657_CR23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-065X.1997.tb00985.x","volume":"157","author":"JH Falkenburg","year":"1997","unstructured":"Falkenburg JH, Smit WM, WillemzeR (1997) Cytotoxic T-lymphocyte (CTL) responses against acute or chronic myeloid leukemia. Immunol Rev 157:223\u2013230","journal-title":"Immunol Rev"},{"issue":"6","key":"657_CR24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00262-002-0284-4","volume":"51","author":"J Galea-Lauri","year":"2002","unstructured":"Galea-Lauri J, Darling D, Mufti G, Harrison P, Farzaneh F (2002) Eliciting cytotoxic T lymphocytes against acute myeloid leukemia-derived antigens: evaluation of dendritic cell-leukemia cell hybrids and other antigen-loading strategies for dendritic cell-based vaccination. Cancer Immunol Immunother 51(6):299\u2013310","journal-title":"Cancer Immunol Immunother"},{"key":"657_CR25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1182\/asheducation-2002.1.73","volume":"1","author":"FJ Giles","year":"2002","unstructured":"Giles FJ, Keating A, Goldstone AH, Avivi I, Willmann CL, Kantarjian HM (2002) Acute myeloid leukemia. Hematology 1:73\u2013110","journal-title":"Hematology"},{"key":"657_CR26","doi-asserted-by":"crossref","unstructured":"Graf M , Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H (2004) High expression of costimulatory molecules correlates with low relapse free-survival-probability in acute myeloid leukemia (AML). Ann Hemat, in press","DOI":"10.1007\/s00277-004-0978-0"},{"issue":"6","key":"657_CR27","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","volume":"89","author":"P Greenberg","year":"1997","unstructured":"Greenberg P, Cox C, LeBeau MM, Fenaux P, Morel P, Sanz G, Sanz M, Vallespi T, Hamblin T, Oscier D, Ohyashiki K, Toyama K, Aul C, Mufti G, Bennett J (1997) International scoring system for evaluating prognosis in myelodysplastic syndromes. Blood 89(6):2079\u20132088","journal-title":"Blood"},{"issue":"2","key":"657_CR28","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1200\/JCO.2003.08.005","volume":"21","author":"T Haferlach","year":"2003","unstructured":"Haferlach T, Schoch C, Loffler H, Gassmann W, Kern W, Schnittger S, Fonatsch C, Ludwig WD, Wuchter C, Schlegelberger B, Staib P, Reichle A, Kubica U, Eimermacher H, Balleisen L, Gruneisen A, Haase D, Aul C, Karow J, Lengfelder E, Wormann B, Heinecke A, Sauerland MC, Buchner T, Hiddemann W (2003) Morphologic dysplasia in de novo acute myeloid leukemia (AML) is related to unfavorable cytogenetics but has no independent prognostic relevance under the conditions of intensive induction therapy: results of a multiparameter analysis from the German AML Cooperative Group studies. J Clin Oncol 21(2):256\u2013265","journal-title":"J Clin Oncol"},{"key":"657_CR29","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood.V97.9.2764","volume":"97","author":"BD Harrison","year":"2001","unstructured":"Harrison BD, Adams JA, Briggs M, Brereton ML, Liu Yin JA (2001) Stimulation of autologous proliferative and cytotoxic T-cell responses by \u201cleukemic dendritic cells\u201d derived from blasts cells in acute myeloid leukemia. Blood 97:2764\u20132771","journal-title":"Blood"},{"issue":"5","key":"657_CR30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/BF02473310","volume":"106","author":"H Hessel","year":"1996","unstructured":"Hessel H, Mittermuller J, Zitzelsberger H, Weier HU, Bauchinger M (1996) Combined immunophenotyping and FISH with sex chromosome-specific DNA probes for the detection of chimerism in epidermal Langerhans cells after sex-mismatched bone marrow transplantation. Histochem Cell Biol 106(5):481\u2013485","journal-title":"Histochem Cell Biol"},{"issue":"Suppl 76","key":"657_CR31","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/BF03165120","volume":"2","author":"H Hirai","year":"2002","unstructured":"Hirai H (2002) Molecular pathogenesis of MDS. Int J Hematol 2(Suppl 76):213\u2013221","journal-title":"Int J Hematol"},{"issue":"2","key":"657_CR32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S1046-2023(03)00120-8","volume":"31","author":"MA Hoorn van der","year":"2003","unstructured":"van der Hoorn MA, van Luxemburg-Heijs SA, van Bergen CA, Bongaerts R, Willemze R, Falkenburg JH (2003) The progenitor cell inhibition assay to measure the anti-leukemic reactivity of T cell clones against acute and chronic myeloid leukemia. Methods 31(2):113\u20139","journal-title":"Methods"},{"issue":"7","key":"657_CR33","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00262-003-0389-4","volume":"52","author":"I Houtenbos","year":"2003","unstructured":"Houtenbos I, Westers TM, Stam AG, de Gruijl TD, Scheper RJ, Ossenkoppele GJ et al (2003) Serum-free generation of antigen presenting cells from acute myeloid leukaemic blasts for active specific immunisation. Cancer Immunol Immunother 52(7):455\u2013462","journal-title":"Cancer Immunol Immunother"},{"issue":"2","key":"657_CR34","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-1759(02)00150-3","volume":"267","author":"N Kienzle","year":"2002","unstructured":"Kienzle N, Olver S, Buttigieg K, Kelso A (2002) The fluorolysis assay, a highly sensitive method for measuring the cytolytic activity of T cells at very low numbers. J Immunol Methods 267(2):99\u2013108","journal-title":"J Immunol Methods"},{"issue":"2","key":"657_CR35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1634\/stemcells.18-2-139","volume":"18","author":"T Koehler","year":"2000","unstructured":"Koehler T, Plettig R, Wetzstein W, Schmitz M, Ritter M, Mohr B et al (2000) Cytokine-driven differentiation of blasts from patients with acute myelogenous and lymphoblastic leukemia into dendritic cells. Stem Cells 18(2):139\u2013147","journal-title":"Stem Cells"},{"key":"657_CR36","doi-asserted-by":"crossref","unstructured":"Kufner S, Kroell T, Pelka- Fleischer R, Salem A, Zitzelsberger H, de Valle F, Zirpel I, Nuessler V, Schmetzer H (2004) Leukemia-derived dendritic cells (DC) can be generated from blood or bone marrow cells from patients with acute myeloid leukemia (AML) or myelodysplasia (MDS): a methodological approach under serum-free culture conditions (submitted for publication)","DOI":"10.1111\/j.1365-3083.2005.01630.x"},{"issue":"12","key":"657_CR37","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nri959","volume":"2","author":"A Lanzavecchia","year":"2002","unstructured":"Lanzavecchia A, Sallusto F (2002) Progressive differentiation and selection of the fittest in the immune response. Nat Rev Immunol 2(12):982\u2013987","journal-title":"Nat Rev Immunol"},{"issue":"Suppl 4","key":"657_CR38","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1016\/S0264-410X(02)00382-1","volume":"20","author":"AW Lee","year":"2002","unstructured":"Lee AW, Truong T, Bickham K, Fonteneau JF, Larsson M, Da Silva I et al (2002) A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy. Vaccine 20(Suppl 4):A8\u2013A22","journal-title":"Vaccine"},{"key":"657_CR39","first-page":"8","volume":"3","author":"L Li","year":"2003","unstructured":"Li L, Schmitt A, Reinhardt P, Greiner J, Ringhoffer M, Vaida B, Bommer M, Vollmer M, Wiesneth M, Dohner H, Schmitt M (2003) Reconstruction of CD40 and CD80 in dendritic cells generated from blasts of patients with acute myeloid leukemia. Cancer Immunol 3:8","journal-title":"Cancer Immunol"},{"issue":"3","key":"657_CR40","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s002620050614","volume":"49","author":"A Mackensen","year":"2000","unstructured":"Mackensen A, Drager R, Schlesier M, Mertelsmann R, Lindemann A (2000) Presence of IgE antibodies to bovine serum albumin in a patient developing anaphylaxis after vaccination with human peptide-pulsed dendritic cells. Cancer Immunol Immunother 49(3):152\u2013156","journal-title":"Cancer Immunol Immunother"},{"key":"657_CR41","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1046\/j.1365-2141.1998.00901.x","volume":"102","author":"A Maeda","year":"1998","unstructured":"Maeda A, Yamamoto K, Yamashita K, Asagoe K, Nohgawa M, Kita K, Iwasaki K, Ueda T, Takahashi A, Sasada M (1998) The expression of costimulatory molecules and their relationship to the prognosis of human acute myeloid leukemia: Poor prognosis of B7.2-positive leukemia. Br J Haematol 102:1257\u20131262","journal-title":"Br J Haematol"},{"issue":"7","key":"657_CR42","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2002-01-0230","volume":"100","author":"M Maynadie","year":"2002","unstructured":"Maynadie M, Picard F, Husson B, Chatelain B, Cornet Y, Le Roux G et al (2002) Immunophenotypic clustering of myelodysplastic syndromes. Blood 100(7):2349\u20132356","journal-title":"Blood"},{"key":"657_CR43","first-page":"An","volume":"to","author":"Mitelman","year":"1995","unstructured":"Mitelman F (ed) (1995) Guidelines for cancer cytogenetics. Supplement to: An International System for Human Cytogenetic Nomenclature (ISCN). S Karger, Basel, Switzerland","journal-title":"Supplement"},{"key":"657_CR44","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/89863","volume":"7","author":"FO Nestle","year":"2001","unstructured":"Nestle FO, Banchereau J, Hart D (2001) Dendritic cells: on the move from the bench to bedside. Nat Med 7:761\u2013765","journal-title":"Nat Med"},{"key":"657_CR45","first-page":"1","volume":"9281","author":"XD Nguyen","year":"2003","unstructured":"Nguyen XD, Eichler H, Dugrillon A, Piechaczek C, Braun M, Klueter H (2003) Flow cytometric analysis of T cell proliferation in a mixed lymphocyte reaction with dendritic cells. J Immunol Methods 9281:1\u201312","journal-title":"J Immunol Methods"},{"issue":"7","key":"657_CR46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s002770000159","volume":"79","author":"L Oehler","year":"2000","unstructured":"Oehler L, Berer A, Kollars M, Keil F, Konig M, Waclavicek M et al (2000) Culture requirements for induction of dendritic cell differentiation in acute myeloid leukemia. Ann Hematol 79(7):355\u2013362","journal-title":"Ann Hematol"},{"issue":"2","key":"657_CR47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0145-2126(01)00104-7","volume":"26","author":"N Panoskaltsis","year":"2002","unstructured":"Panoskaltsis N, Belanger TJ, Liesveld JL, Abboud CN (2002) Optimal cytokine stimulation for the enhanced generation of leukemic dendritic cells in short-term culture. Leuk Res 26(2):191\u2013201","journal-title":"Leuk Res"},{"key":"657_CR48","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1084\/jem.177.2.265","volume":"177","author":"NP Restifo","year":"1993","unstructured":"Restifo NP, Esquivel F, Kawakami Y et al (1993) Identification of human cancers deficient in antigen processing. J Exp Med 177:265\u2013272","journal-title":"J Exp Med"},{"key":"657_CR49","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1046\/j.1365-2141.1999.01781.x","volume":"107","author":"GM Rigolin","year":"1999","unstructured":"Rigolin GM, Howard J, Buggins A, Sneddon C, Castoldi G, Hirst WJR et al (1999) Phenotypic and functional characteristics of monocyte-derived dendritic cells from patients with myelodyplastic syndromes. Br J Haematol 107:844\u2013850","journal-title":"Br J Haematol"},{"issue":"Suppl 3","key":"657_CR50","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/ar567","volume":"4","author":"F Sallusto","year":"2002","unstructured":"Sallusto F, Lanzavecchia A (2002) The instructive role of dendritic cells on T-cell responses. Arthritis Res 4(Suppl 3):127\u2013132","journal-title":"Arthritis Res"},{"issue":"9","key":"657_CR51","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1182\/blood.V84.9.3054.3054","volume":"84","author":"F Santiago-Schwarz","year":"1994","unstructured":"Santiago-Schwarz F, Coppock DL, Hindenburg AA, Kern J (1994) Identification of a malignant counterpart of the monocyte-dendritic cell progenitor in an acute myeloid leukemia. Blood 84(9):3054\u20133062","journal-title":"Blood"},{"issue":"12","key":"657_CR52","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.1349-7006.2003.tb01405.x","volume":"94","author":"M Sato","year":"2003","unstructured":"Sato M, Takayama T, Tanaka H, Konishi J, Suzuki T, Kaiga T, Tahara H (2003) Generation of mature dendritic cells fully capable of T helper type 1 polarization using OK-432 combined with prostaglandin E(2). Cancer Sci 94(12):1091\u20131098","journal-title":"Cancer Sci"},{"issue":"2","key":"657_CR53","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S0952-7915(03)00015-3","volume":"15","author":"G Schuler","year":"2003","unstructured":"Schuler G, Schuler-Thurner B, Steinman RM (2003) The use of dendritic cells in cancer immunotherapy. Curr Opin Immunol 15(2):138\u2013147","journal-title":"Curr Opin Immunol"},{"issue":"6","key":"657_CR54","first-page":"503","volume":"35","author":"LP Song","year":"2003","unstructured":"Song LP, Cheng JL, Wang XB, Zhang Z, Fang M, Zhou ZY et al (2003) A new model of trispecific antibody resulting the cytotoxicity directed against tumor cells. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 35(6):503\u2013510","journal-title":"Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai)"},{"key":"657_CR55","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1038\/sj.leu.2402701","volume":"16","author":"R Stripecke","year":"2002","unstructured":"Stripecke R, Levine AM, Pullarkat V, Cardoso AA (2002) Immunotherapy with acute leukemia cells modified into antigen-presenting cells: ex vivo culture and gene transfer methods. Leukemia 16:1974\u20131983","journal-title":"Leukemia"},{"issue":"4","key":"657_CR56","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/blood.V90.4.1425","volume":"90","author":"H Strobl","year":"1997","unstructured":"Strobl H, Bello-Fernandez C, Riedl E, Pickl WF, Majdic O, Lyman SD et al (1997) flt3 ligand in cooperation with transforming growth factor-beta1 potentiates in vitro development of Langerhans-type dendritic cells and allows single-cell dendritic cell cluster formation under serum-free conditions. Blood 90(4):1425\u20131434","journal-title":"Blood"},{"issue":"5","key":"657_CR57","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/146532401753277184","volume":"3","author":"Y Suen","year":"2001","unstructured":"Suen Y, Lee SM, Aono F, Hou S, Loudovaris M, Ofstein G et al (2001) Comparison of monocyte enrichment by immuno-magnetic depletion or adherence for the clinical-scale generation of DC. Cytotherapy 3(5): 365\u2013375","journal-title":"Cytotherapy"},{"issue":"5","key":"657_CR58","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s00262-002-0352-9","volume":"52","author":"PA Trail","year":"2003","unstructured":"Trail PA, King HD, Dubowchik GM (2003) Monoclonal antibody drug immunoconjugates for targeted treatment of cancer. Cancer Immunol Immunother 52(5):328\u2013337","journal-title":"Cancer Immunol Immunother"},{"issue":"6","key":"657_CR59","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/cncr.11239","volume":"97","author":"A Tsimberidou","year":"2003","unstructured":"Tsimberidou A, Estey E, Cortes J, Thomas D, Faderl S, Verstovsek S et al (2003) Gemtuzumab, fludarabine, Cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes. Cancer 97(6):1481\u20131487","journal-title":"Cancer"},{"issue":"1","key":"657_CR60","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02981980","volume":"75","author":"T Tsuchiya","year":"2002","unstructured":"Tsuchiya T, Hagihara M, Shimakura Y, Ueda Y, Gansuvd B, Munkhbat B, Inoue H, Tazume K, Kato S, Hotta T (2002) The generation of immunocompetent dendritic cells from CD34+ acute myeloid or lymphoid leukemia cells. Int J Hematol 75(1):55\u201362","journal-title":"Int J Hematol"},{"issue":"16","key":"657_CR61","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1056\/NEJM199510193331603","volume":"333","author":"EA Walter","year":"1995","unstructured":"Walter EA, Greenberg PD, Gilbert MJ, Finch RJ, Watanabe KS, Thomas ED, Riddell SR (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N Engl J Med 333(16):1038\u20131044","journal-title":"N Engl J Med"},{"issue":"3","key":"657_CR62","first-page":"161","volume":"8","author":"L Wang","year":"2000","unstructured":"Wang L, Chen S, Liu Y, Fu J, Yu H, Li J et al (2000) The function of dendritic cells derived from chronic myeloid leukemia. Zhongguo Shi Yan Xue Za Zhi 8(3):161\u2013165","journal-title":"Zhongguo Shi Yan Xue Za Zhi"},{"key":"657_CR63","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/sj.leu.2402013","volume":"15","author":"A Woiciechowsky","year":"2001","unstructured":"Woiciechowsky A, Regn S, Kolb H-I, Roskrow M (2001) Leukemic dendritic cells generated in the presence of FLT3 ligand have the capacity to stimulate an autologous leukemia-specific cytotoxic T cell response from patients with acute myeloid leukemia. Leukemia 15:246\u2013255","journal-title":"Leukemia"},{"issue":"10","key":"657_CR64","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1053\/bbmt.2002.v8.pm12434951","volume":"8","author":"RK Zhong","year":"2002","unstructured":"Zhong RK, Rassenti LZ, Kipps TJ, Chen J, Law P, Yu JF, Ball ED (2002) Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia. Biol Blood Marrow Tr 8(10):557\u2013568","journal-title":"Biol Blood Marrow Tr"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0657-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00262-004-0657-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-004-0657-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T12:16:56Z","timestamp":1586175416000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00262-004-0657-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,24]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["657"],"URL":"https:\/\/doi.org\/10.1007\/s00262-004-0657-y","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,24]]}}}